Did Hedge Funds Drop The Ball On Alimera Sciences Inc (ALIM) ?
"The global economic environment is very favorable for investors. Economies are generally strong, but not too strong. Employment levels are among the strongest for many decades.
Alimera Sciences Inc (ALIM)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
13G Filing: Palo Alto Investors and Alimera Sciences Inc (ALIM)
The names of the persons filing this statement are:Palo Alto Investors, LLC ("PAI LLC")Patrick Lee, MDAnthony Joonkyoo Yun, MDPalo Alto Healthcare Master Fund, L.P.
13D Filing: Intersouth Partners VI LP and Alimera Sciences Inc (ALIM)
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information...
Is Alimera Sciences Inc (ALIM) A Good Stock To Buy?
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively...
Alimera Sciences Inc (ALIM): Great Point Partners Reveals 5.12% Stake
Jeffrey Jay and David Kroin's Great Point Partners reported the acquisition of 3.25 million common shares of Alimera Sciences Inc (NASDAQ:ALIM) which account for 5.12% of the company's outstanding stock...
Tempur Sealy (TPX), GrubHub (GRUB), United States Steel Corporation (X) Among Top Weekly Gainers
It was a mixed week for the market last week, as the Dow gave up 0.75% of its value, while the S&P 500 was down slightly, and the Nasdaq was 1.21% in the green.
Tiger Global Cuts Stake in Autohome, While Deerfield Buys More Shares of This Pharmaceutical Company
Federal funds future contracts suggest a 79% probability that the Federal Reserve will raise interest rates at the December policy meeting, an event which is expected to halt the U.S equities lengthy...
Three Healthcare Stocks Hedge Funds Are Snapping Up
Is it a good time to buy Alimera Sciences Inc (NASDAQ:ALIM)? James E. Flynn thinks so, having recently acquired 321,784 shares of the pharmaceutical company at prices ranging from $2.10-to-$2.50.
Jeffrey Ray's Great Point Partners Trims Its Stake In Alcobra Ltd (ADHD)
Jeffrey Jay and David Kroin's healthcare-focused fund, Great Point Partners, decreased its passive stake in the Israel based biopharmaceutical company, Alcobra Ltd (NASDAQ:ADHD), according to a recent...
Connecture Inc (CNXR), Hyperion Therapeutics Inc (HPTX): Top 5 Healthcare Picks of Great Point Partners
Jeffrey Jay and David Kroin’s Great Point Partners is one of the newer funds we track at Insider Monkey, and we’ll cover the healthcare-focused fund’s top picks for the first time.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
